You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.
IRDAI approves Max India's stake divestment in Max Bupa
Gauging Supply Chain Risk In Volatile Times
Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools
Cannabis: Hashing Out a Budding Industry
2018 US Property Casualty Insurance Market Report
The Insurance Regulatory and Development Authority of India approved True North Fund VI LLP's purchase of Max India Ltd.'s 51% stake in Max Bupa Health Insurance Co. Ltd.
Max India announced the all-cash transaction in February. The acquisition, which is now set to close within the next few weeks, valued Max Bupa at an enterprise value of 10.01 billion rupees.
Max Bupa is a joint venture between U.K.-based Bupa and Max India.
As of Dec. 2, US$1 was equivalent to 71.66 Indian rupees.